A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2002
12/19/2002	CA2449571A1 Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
12/19/2002	CA2449519A1 Controlled release dosage forms using acrylic polymer, and process for making the same
12/19/2002	CA2449440A1 Structural and cytoskeleton-associated proteins
12/19/2002	CA2449272A1 Intracellular signaling molecules
12/19/2002	CA2449249A1 Nr2b receptor antagonists for the treatment or prevention of migraines
12/19/2002	CA2449247A1 A method for treating inflammatory diseases by administering a ppar-delta agonist
12/19/2002	CA2449213A1 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	CA2449189A1 Naphtothiazine positive allosteric ampa receptor modulators (paarm)
12/19/2002	CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	CA2448518A1 New compounds useful in reflux disease
12/19/2002	CA2447687A1 Substituted 1-benzazepines and derivatives thereof
12/19/2002	CA2446223A1 Stabilized dispersion of phytosterol in oil
12/19/2002	CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/19/2002	CA2445471A1 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotic acetylcholine receptors
12/19/2002	CA2445467A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
12/18/2002	EP1267171A1 Cofactor-based screening method for nuclear receptor modulators
12/18/2002	EP1266660A1 Heme oxygenase-1 inducers or induction enhancers
12/18/2002	EP1266656A1 Anionic exchange polymer complexes of buspirone
12/18/2002	EP1266227A1 Synergistic activation of regulatory elements by rel proteins and a steroid receptor
12/18/2002	EP1266029A1 Diagnosis of a person's risk of developing alcoholism
12/18/2002	EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002	EP1266012A2 Proteases
12/18/2002	EP1266008A2 Acute neuronal induced calcium binding protein type 1 ligand
12/18/2002	EP1266002A2 Il-17 receptor like molecules and uses thereof
12/18/2002	EP1266001A2 Human transcription factors
12/18/2002	EP1265999A2 Human schizophrenia gene
12/18/2002	EP1265995A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
12/18/2002	EP1265989A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
12/18/2002	EP1265919A2 G-protein associated molecules
12/18/2002	EP1265916A2 Therapeutic anti-cytomegalovirus compounds
12/18/2002	EP1265905A1 Il-8 receptor antagonists
12/18/2002	EP1265904A1 Novel positive allosteric ampa receptor modulators (paarm), method for the production and use thereof as medicaments
12/18/2002	EP1265900A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
12/18/2002	EP1265899A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/18/2002	EP1265896A1 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
12/18/2002	EP1265894A1 Crystalline form vii of cabergoline
12/18/2002	EP1265891A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/18/2002	EP1265883A1 Method for the preparation of citalopram
12/18/2002	EP1265882A1 Method for the preparation of citalopram
12/18/2002	EP1265881A1 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
12/18/2002	EP1265880A1 Method for the preparation of citalopram
12/18/2002	EP1265878A1 A process for the preparation of epothiline analogs and intermediates
12/18/2002	EP1265870A1 New ccr5 modulators: benzimidazoles or benzotriazoles
12/18/2002	EP1265868A2 Dibenzo (b,f) azepine intermediates
12/18/2002	EP1265866A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
12/18/2002	EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
12/18/2002	EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors
12/18/2002	EP1265862A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/18/2002	EP1265860A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
12/18/2002	EP1265859A2 Amidino compounds useful as nitric oxide synthase inhibitors
12/18/2002	EP1265857A1 Sulfonamide derivatives
12/18/2002	EP1265853A1 Carboxylic acid derivatives as ip antagonists
12/18/2002	EP1265849A2 Compounds and methods to treat alzheimer's disease
12/18/2002	EP1265848A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
12/18/2002	EP1265840A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
12/18/2002	EP1265839A1 Compounds active at the glucocorticoid receptor
12/18/2002	EP1265639A1 The use of anticoagulant agents in the extracorporeal treatment of blood
12/18/2002	EP1265616A2 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
12/18/2002	EP1265610A1 Method for reducing or eliminating smoking
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP1265603A2 Il-8 receptor antagonists
12/18/2002	EP1265602A2 Use of substances modulating the expression or the function of a protein involved in the cell cycle for treating or preventing acute neural injuries
12/18/2002	EP1265600A2 Headache and colic relief composition with asafetida and method of use thereof
12/18/2002	EP1124814B1 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level
12/18/2002	EP1119564B1 Aryl- 4-fluoro-4- (2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl -methanone derivatives as 5-ht1 receptor antagonists
12/18/2002	EP1104420B1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors
12/18/2002	EP1086101B1 Beta-carboline compounds
12/18/2002	EP1079833A4 Cocaine receptor binding ligands
12/18/2002	EP1025101B1 Naphtho-imidazo 1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders
12/18/2002	EP1017275A4 Polyamine treatment of neurological disorders
12/18/2002	EP0946502B1 Sulfonamide interleukin-beta converting enzyme inhibitors
12/18/2002	EP0934300B1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/18/2002	EP0930887B1 Cancer immunotherapy using tumor cells combined with mixed lymphocytes
12/18/2002	EP0880526B1 Heterocycle-condensed morphinoid derivatives (ii)
12/18/2002	EP0876818B1 Agent for treating neuro-degenerative disorders
12/18/2002	EP0873309B1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
12/18/2002	EP0871473B1 Use of il-10 for wound healing with reduced scarring
12/18/2002	EP0859784B1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
12/18/2002	EP0630255B1 Mhc conjugates useful in ameliorating autoimmunity
12/18/2002	CN1386118A Lactams substituted by cyclic succinates as inhibitors of A beta protein production
12/18/2002	CN1385429A High-tension condensed ring nicotine analogue, preparation process and use thereof
12/18/2002	CN1385412A Method for extracting hypericin from Hypericum perforatum and medicine made up using hypericin as main composition
12/18/2002	CN1385196A Multi-function health care food and application thereof
12/18/2002	CN1385195A Health care formula for relieving alcoholism, dispelling alcohol effects and protecting liver
12/18/2002	CN1385194A Biological preparation for improving sleeping
12/18/2002	CN1385180A Compound composite medicine for giving up drug-taking
12/18/2002	CN1385157A Application of protopine in preparing medicine for treating senile dementia
12/18/2002	CN1385156A Application of anethole trithione in pharmacy
12/18/2002	CN1096464C 2,3-benzodiazepine derivatives, its preparation and intermediate and use as medicine
12/18/2002	CN1096278C Medicine for treating trigeminal neuralgia
12/18/2002	CN1096277C Perfume liquid extract capable of improving indoor air and regulating qi and blood
12/18/2002	CN1096274C Drug-dropping tablet and its preparing process
12/18/2002	CN1096273C Drug-dropping cigarette and its preparing process
12/18/2002	CN1096272C Drug-dropping syrup and its preparing process
12/18/2002	CA2388761A1 Wound healing biomarkers
12/17/2002	US6495688 Used as corticotropin-releasing factor (crf) antagonists, in therapy and diagnosis of stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety
12/17/2002	US6495686 Therapy for psychological disorders
12/17/2002	US6495681 Local anesthetic compounds and uses
12/17/2002	US6495606 Administering s-((r)-2-(1-iminoethylamino)propyl)-l-cysteine
12/17/2002	US6495605 Pure isomers

1 ... 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 ... 1833